Skip to main content
. 2020 Oct 1;4(10):bvaa123. doi: 10.1210/jendso/bvaa123

Table 2.

Potential somatic mutations in APA_UM16 after whole-exome sequencing

No. Chr Position Validated by Sanger sequencing Validated by targeted amplicon sequencing Gene Type Amino acid change VF (tumor) VF (normal)
1 3 184076912 Yes Yes CLCN2 Missense p.G24D 52/174 (30%) 0/76 (0%)
2 3 173996717 No No NLGN1 Missense p.P309L 15/62 (24%) 0/57 (0%)
3 14 20876109 No No TEP1 Frameshift p.K164fs 8/82 (10%) 0/65 (0%)
4 9 131020795 No No GOLGA2 Disruptive_Inframe_Deletion p.Glu715del 15/117 (13%) 0/47 (0%)
5 14 23549878 No No ACIN1 Disruptive_Inframe_Deletion p.Glu280del 8/80 (10%) 1/67 (1%)
6 2 67631670 No No ETAA1 Inframe_Deletion p.Leu649_Lys677del 7/81 (9%) 0/63 (0%)
7 3 158450159 No No RARRES1 Start_Lost and Inframe_Deletion p.Met1_Pro15del 6/109 (6%) 0/67 (0%)
8 3 130743760 No No ASTE1 Missense p.Arg131Trp 6/94 (6%) 0/8 2(0%)
9 17 42756274 No No CCDC43 Missense p.Arg209Cys 6/113 (5%) 0/87 (0%)
10 22 40391306 No No FAM83F Inframe_Deletion p.Lys92_Ala93del 10/197 (5%) 0/134(0%)
11 1 8716291 No No RERE Disruptive_Inframe_Deletion p.Asp18_Arg21del 6/119 (5%) 0/86 (0%)

Abbreviations: APA, aldosterone-producing adenoma; Chr, chromosome; VF, variant allele frequency.